CO 025: PRINCIPLE OF REDUCTION AND THE VALIDITY AND EFFICIENCY OF ANIMAL ASSAYS

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S14, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 025: PRINCIPLE OF REDUCTION AND THE VALIDITY AND EFFICIENCY OF ANIMAL ASSAYS Rosenkranz A. Bioterio Central, FCEyN, Universidad de Buenos Aires, Argentina. E-mail: rosenkranza@yahoo.com.ar Abstract According the International Guiding Principles animals should only be used … Continue reading CO 025: PRINCIPLE OF REDUCTION AND THE VALIDITY AND EFFICIENCY OF ANIMAL ASSAYS

J Pharm Pharmacogn Res 2(Suppl. 1): S14, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 025: PRINCIPLE OF REDUCTION AND THE VALIDITY AND EFFICIENCY OF ANIMAL ASSAYS

Rosenkranz A.

Bioterio Central, FCEyN, Universidad de Buenos Aires, Argentina. E-mail: rosenkranza@yahoo.com.ar
Abstract

According the International Guiding Principles animals should only be used when necessary and the Principles of the Three Rs should be incorporated in the design and conduct of the activities and, when no alternative methods are available to replace the use of live animals, the minimum number of animals should be used to achieve the goals. The most important international Journals require the authors to follow International Guidelines like the Guide for the Care and Use of Laboratory Animals, NRC, USA, that request for justification of the number of animals and experimental group sizes. In order to assure valid and reproducible experiments it is imperative to use animals with a defined dramatype. Factors such as: species, strains, sex, age, weight, cage, bedding , temperature, humidity, air velocity, noise, light, odors, day of the week, circadian rhythms, nutrition, presence of microorganisms, human/animal interaction, order of administration of substances and order of euthanasia may affect the response of the animals and introduce bias or lower the precision of the results of the experiments. Adequate reporting of the conditions of animal use are important to enable replication, and also to allow readers to judge scientific quality, but analyses of published studies with research animals have demonstrated numerous deficiencies in the reporting of details of research methods for animal studies and many papers omitted the number of animals used. An unspoken industry rule alleges that at least 50% of published studies from academic laboratories cannot be repeated in an industrial setting, Unavoidable variability could be controlled using an experimental design with randomized blocks. The range of applicability might be extended using factorial designs. The analysis should always be appropriate to the type of experimental design used. Several studies demonstrate that inappropriate statistical methods were used in more than 60% of papers. The editors of scientific journals should promote high-quality reporting.

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio